Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Medikit Co's Debt-to-Equity or its related term are showing as below:
TSE:7749's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.24 * Ranked among companies with meaningful Debt-to-Equity only.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Medikit Co Debt-to-Equity Related Terms
Medikit Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Medikit Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7749 vs ISRG, BDX, RMD: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Medikit Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medikit Co Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Medikit Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medikit Co (TSE:7749) has a Debt-to-Equity of 0.00 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medikit Co and its competitors. According to the industry distribution chart, Medikit Co ranks #999999 out of 697 companies in the Medical Devices & Instruments industry.
Is Medikit Co's Debt-to-Equity too high?
Medikit Co's current Debt-to-Equity is 0.00. Based on the distribution chart, Medikit Co ranks #999999 out of 697 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medikit Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #999999 out of 697 companies for Debt-to-Equity. This places Medikit Co in the lower half of its industry. The industry median Debt-to-Equity is 0.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Medikit Co and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Fairly Valued. The stock's GF Value™ is 円3,238.61, compared to a current price of 円2,965.00 — trading 8.4% below its estimated fair value. The current Debt-to-Equity is 0.00. Medikit Co's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current Debt-to-Equity is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medikit Co (TSE:7749) Overvalued in 2026?
Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued.
The current stock price of 円2,965.00 is trading 8.4% below its estimated GF Value™ of 円3,238.61.
GuruFocus considers Medikit Co to be Fairly Valued.
Key valuation signals for TSE:7749:
Debt-to-Equity: 0.00
GF Value™: 円3,238.61 vs. price of 円2,965.00 (8.4% below fair value)
No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
86GF Score
Get the complete analysis for TSE:7749
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7749 has been successfully added to your 
